{"id":738,"date":"2022-09-22T20:32:01","date_gmt":"2022-09-22T20:32:01","guid":{"rendered":"https:\/\/newsletters.aans.org\/tumor\/?page_id=738"},"modified":"2022-09-22T20:32:01","modified_gmt":"2022-09-22T20:32:01","slug":"innovation-and-technology","status":"publish","type":"page","link":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/innovation-and-technology\/","title":{"rendered":"Innovation and Technology"},"content":{"rendered":"<p><em>Formerly Radiosurgery, LITT<\/em><\/p>\n<p><strong>Chair:<\/strong> Chris Cifarelli, MD, PhD, FAANS<img loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-739\" src=\"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/09\/Lola-Chambless.jpg\" alt=\"Lola Chambless\" width=\"94\" height=\"122\" \/> <img loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-740\" src=\"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/09\/Chris-Cifarelli.jpg\" alt=\"Chris Cifarelli\" width=\"106\" height=\"126\" \/><br \/>\n<strong>Co-Chair<\/strong>: Lola Chambless, MD, FAANS<br \/>\n<strong>Members<\/strong>: Clark Chen, MD, PhD, FAANS, Pamela Jones, MD, MS, MPH, FAANS, Claire Karekezi, MD, Alexandra Golbi, MD, FAANS, Pablo Recinos, MD, FAANS, Michael Sughrue, MD, and Brian Williams, MD<\/p>\n<p>While our management of CNS tumors regularly incorporates the use of established and new tech, the availability of guidelines for such can lag for years after introduction based on paucity of published data. Similarly, new applications for existing tech continue to evolve, often requiring a re-examination of previously vetted processes. As the gold standard for new devices and agents will remain clinical trial investigation, such efforts are often preceded by the early adoption of new technology by a relatively small group of clinicians.<\/p>\n<p>The mission of our subcommittee is to provide a reliable compilation of current and emerging tech as it relates to tumor treatment and care delivery. From this, our membership can identify the early adopters and evaluate the potential of new tech to be advanced within the field. With dedicated content experts in several areas of neurosurgical oncology, we aim to share our findings via webinars, review publications and across the Tumor Section membership by direct engagement at the CNS, AANS and Tumor Satellite meeting.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Formerly Radiosurgery, LITT Chair: Chris Cifarelli, MD, PhD, FAANS Co-Chair: Lola Chambless, MD, FAANS Members: Clark Chen, MD, PhD, FAANS, Pamela Jones, MD, MS, MPH, FAANS, Claire Karekezi, MD, Alexandra Golbi, MD, FAANS, Pablo Recinos, MD, FAANS, Michael Sughrue, MD, and Brian Williams, MD While our management of CNS tumors regularly incorporates the use of [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":673,"menu_order":13,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-738","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Innovation and Technology - Tumor News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/innovation-and-technology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Innovation and Technology - Tumor News\" \/>\n<meta property=\"og:description\" content=\"Formerly Radiosurgery, LITT Chair: Chris Cifarelli, MD, PhD, FAANS Co-Chair: Lola Chambless, MD, FAANS Members: Clark Chen, MD, PhD, FAANS, Pamela Jones, MD, MS, MPH, FAANS, Claire Karekezi, MD, Alexandra Golbi, MD, FAANS, Pablo Recinos, MD, FAANS, Michael Sughrue, MD, and Brian Williams, MD While our management of CNS tumors regularly incorporates the use of [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/innovation-and-technology\/\" \/>\n<meta property=\"og:site_name\" content=\"Tumor News\" \/>\n<meta property=\"og:image\" content=\"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/09\/Lola-Chambless.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/fall-2022\\\/innovation-and-technology\\\/\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/fall-2022\\\/innovation-and-technology\\\/\",\"name\":\"Innovation and Technology - Tumor News\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/fall-2022\\\/innovation-and-technology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/fall-2022\\\/innovation-and-technology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/newsletters.aans.org\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2022\\\/09\\\/Lola-Chambless.jpg\",\"datePublished\":\"2022-09-22T20:32:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/fall-2022\\\/innovation-and-technology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/fall-2022\\\/innovation-and-technology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/fall-2022\\\/innovation-and-technology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2022\\\/09\\\/Lola-Chambless.jpg\",\"contentUrl\":\"https:\\\/\\\/newsletters.aans.org\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2022\\\/09\\\/Lola-Chambless.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/fall-2022\\\/innovation-and-technology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tumor News Fall 2022\",\"item\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/fall-2022\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Innovation and Technology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#website\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/\",\"name\":\"Tumor News\",\"description\":\"Just another AANS Newsletter Sites site\",\"publisher\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#organization\",\"name\":\"Tumor News\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2024\\\/11\\\/JST.2024.logo_.png\",\"contentUrl\":\"https:\\\/\\\/newsletters.aans.org\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2024\\\/11\\\/JST.2024.logo_.png\",\"width\":2336,\"height\":2294,\"caption\":\"Tumor News\"},\"image\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Innovation and Technology - Tumor News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/innovation-and-technology\/","og_locale":"en_US","og_type":"article","og_title":"Innovation and Technology - Tumor News","og_description":"Formerly Radiosurgery, LITT Chair: Chris Cifarelli, MD, PhD, FAANS Co-Chair: Lola Chambless, MD, FAANS Members: Clark Chen, MD, PhD, FAANS, Pamela Jones, MD, MS, MPH, FAANS, Claire Karekezi, MD, Alexandra Golbi, MD, FAANS, Pablo Recinos, MD, FAANS, Michael Sughrue, MD, and Brian Williams, MD While our management of CNS tumors regularly incorporates the use of [&hellip;]","og_url":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/innovation-and-technology\/","og_site_name":"Tumor News","og_image":[{"url":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/09\/Lola-Chambless.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/innovation-and-technology\/","url":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/innovation-and-technology\/","name":"Innovation and Technology - Tumor News","isPartOf":{"@id":"https:\/\/newsletters.aans.org\/tumor\/#website"},"primaryImageOfPage":{"@id":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/innovation-and-technology\/#primaryimage"},"image":{"@id":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/innovation-and-technology\/#primaryimage"},"thumbnailUrl":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/09\/Lola-Chambless.jpg","datePublished":"2022-09-22T20:32:01+00:00","breadcrumb":{"@id":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/innovation-and-technology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/newsletters.aans.org\/tumor\/fall-2022\/innovation-and-technology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/innovation-and-technology\/#primaryimage","url":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/09\/Lola-Chambless.jpg","contentUrl":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/09\/Lola-Chambless.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/innovation-and-technology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/newsletters.aans.org\/tumor\/"},{"@type":"ListItem","position":2,"name":"Tumor News Fall 2022","item":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/"},{"@type":"ListItem","position":3,"name":"Innovation and Technology"}]},{"@type":"WebSite","@id":"https:\/\/newsletters.aans.org\/tumor\/#website","url":"https:\/\/newsletters.aans.org\/tumor\/","name":"Tumor News","description":"Just another AANS Newsletter Sites site","publisher":{"@id":"https:\/\/newsletters.aans.org\/tumor\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/newsletters.aans.org\/tumor\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/newsletters.aans.org\/tumor\/#organization","name":"Tumor News","url":"https:\/\/newsletters.aans.org\/tumor\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/newsletters.aans.org\/tumor\/#\/schema\/logo\/image\/","url":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2024\/11\/JST.2024.logo_.png","contentUrl":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2024\/11\/JST.2024.logo_.png","width":2336,"height":2294,"caption":"Tumor News"},"image":{"@id":"https:\/\/newsletters.aans.org\/tumor\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages\/738","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/comments?post=738"}],"version-history":[{"count":1,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages\/738\/revisions"}],"predecessor-version":[{"id":741,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages\/738\/revisions\/741"}],"up":[{"embeddable":true,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages\/673"}],"wp:attachment":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/media?parent=738"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}